Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Breaking the 5-year barrier: results from the MA.17 extended adjuvant trial in women who have completed adjuvant tamoxifen treatment

Breaking the 5-year barrier: results from the MA.17 extended adjuvant trial in women who have completed adjuvant tamoxifen treatment. European Journal of Cancer Supplements 4(9) - Proceedings of the satellite symposium ’The quiet revolution in breast cancer treatment: how aromatase inhibitors are displacing tamoxifen’. 2006; 4, Issue 9:10-15.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.